Top-down analytical platforms for the characterization of the human salivary proteome

Bioanalysis

Volumn 6, Issue 4, 2014, Pages 563-581

  Cabras, Tiziana ^a   Iavarone, Federica ^b   Manconi, Barbara ^a   Olianas, Alessandra ^a   Sanna, Maria Teresa ^a   Castagnola, Massimo ^b   Messana, Irene ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; GLYCOSYLATED PROTEIN; METHIONINE; OLIGOSACCHARIDE; PEPTIDE; PEPTIDE DERIVATIVE; PROTEIN DERIVATIVE; PROTEIN VARIANT; PROTEOME; SALIVA PROTEIN; SECRETORY PROTEIN; SULFUR DERIVATIVE;

AMINO TERMINAL SEQUENCE; ANALYTIC METHOD; CARBOHYDRATE ANALYSIS; CARBOXY TERMINAL SEQUENCE; DIAGNOSTIC TEST; ELECTROSPRAY MASS SPECTROMETRY; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN DEFECT; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEOMICS; REVIEW; SALIVA ANALYSIS; SALIVA LEVEL; SAMPLE SIZE; SULFATION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MASS SPECTROMETRY; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOME; PROTEOMICS; SALIVA;

EID: 84896877516     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.13.349     Document Type: Review

References (134)

1. Bogdanov B, Smith RD. Proteomics by FTICR mass spectrometry: top down and bottom up. Mass Spectrom. Rev. 24(2), 168-200 (2005). (Pubitemid 40328973)
2. Tipton JD, Tran JC, Catherman AD et al. Analysis of intact protein isoforms by mass spectrometry. J. Biol. Chem. 286(29), 25451-25458 (2011).
3. Castagnola M, Cabras T, Iavarone F et al. The human salivary proteome: a critical overview of the results obtained by different proteomic platforms. Expert Rev. Proteomics 9(1), 33-46 (2012).
4. Messana I, Cabras T, Iavarone F et al. Unraveling the different proteomic platforms. J. Sep. Sci. 36(1), 128-139 (2013).
5. Meyer B, Papasotiriou DG. Karas M 100% protein sequence coverage: a modern form of surrealism in proteomics. Amino Acids 41(2), 291-310 (2011).
6. Castagnola M, Cabras T, Iavarone F et al. Top-down platform for deciphering the human salivary proteome. J. Matern. Fetal Neonatal Med. 25(Suppl. 5), 27-43 (2012).
7. Whitelegge JP, Zabrouskov V, Halgand F et al. Protein-sequence polymorphisms and post-translational modifications in proteins from human saliva using top-down Fourier-transform ion cyclotron resonance mass spectrometry. Int. J. Mass Spectrom. 268(2-3), 190-197 (2007).
8. Halgand F, Zabrouskov V, Bassilian S et al. Defining intact protein primary structures from saliva: a step toward the human proteome project. Anal. Chem. 84(10), 4383-4395 (2012).
9. Fábián TK, Fejérdy P, Csermely P. Saliva in health and disease (chemical biology of). In: Wiley Encyclopedia of Chemical Biology, Volume 4 (1st Edition). Begley TP (Ed.). John Wiley & Sons, Inc., NJ, USA, 1-9 (2008).
10. Bandhakavi S, Stone MD, Onsongo G et al. A dynamic range compression and three-dimensional peptide fractionation analysis platform expands proteome coverage and the diagnostic potential of whole saliva. J. Proteome Res. 8(12), 5590-5600 (2009).
11. Messana I, Cabras T, Pisano E et al. Trafficking and postsecretory events responsible for the formation of secreted human salivary peptides: a proteomics approach. Mol. Cell. Proteomics 7(5), 911-926 (2008). • Results of the study give useful information on the spatial and temporal relationships of the modifications the proteins undergo from their synthesis to their isolation from whole saliva. (Pubitemid 351737091)
12. Helmerorst EJ, Sun X, Salih E, Oppenheim FG. Identification of Lys-Prof-Gln as a novel cleavage site specificity of saliva-associated proteases. J. Biol. Chem. 283(29), 19957-19966 (2008).
13. Hirtz C, Chevalier F, Centeno D et al. MS characterization of multiple forms of alpha-amylase in human saliva. Proteomics 5(17), 4597-4607 (2005). (Pubitemid 41739937)
14. Bailey UM, Punyadeera C, Cooper-White JJ, Schulz BL. Analysis of the extreme diversity of salivary alpha-amylase isoforms generated by physiological proteolysis using liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 911, 21-26 (2012).
15. Ramachandran P, Boontheung P, Xie Y et al. Identification of N-linked glycoproteins in human saliva by glycoprotein capture and mass spectrometry. J. Proteome Res. 5(6), 1493-1503 (2006). (Pubitemid 43865819)
16. Peng Y, Chen X, Sato T et al. Purification and high-resolution top-down mass spectrometric characterization of human salivary a-amylase. Anal. Chem. 84(7), 3339-3346 (2012).
17. Helmerhorst EJ, Oppenheim FG. Saliva: a dynamic proteome. J. Dent. Res. 86(8), 680-693 (2007). • ?Outlines that the proteome of whole saliva is dynamic. This aspect should be taken into account to identify meaningful biomarkers for oral diseases.
18. Salih E, Siqueira WL, Helmerhorst EL, Oppenheim FG. Large-scale phosphoproteome of human whole saliva using disulfide-thiol interchange covalent chromatography and mass spectrometry. Anal. Biochem. 407(1), 19-33 (2010).
19. Dickinson DP. Salivary (SD-type) cystatins: over one billion years in the making - but to what purpose? Crit. Rev. Oral Biol. Med. 13(6), 485-508 (2002). (Pubitemid 36570022)
20. Castagnola M, Inzitari R, Rossetti DV et al. A cascade of 24 histatins (histatin 3 fragments) in human saliva. Suggestions for a pre-secretory sequential cleavage pathway. J. Biol. Chem. 279(40), 41436-41443 (2004). (Pubitemid 39313584)
21. Cabras T, Fanali C, Monteiro JA et al. Tyrosine polysulfation of human salivary histatin 1. A post-translational modification specific of the submandibular gland. J. Proteome Res. 6(7), 2472-2480 (2007). (Pubitemid 47122343)
22. Tran JC, Doucette AA. Multiplexed size separation of intact proteins in solution phase for mass spectrometry. Anal. Chem. 81(15), 6201-6209 (2009).
23. Tran JC, Zamdborg L, Ahlf DR et al. Mapping intact protein isoforms in discovery mode using top-down proteomics. Nature 480(7376), 254-258 (2011).
24. Sondej M, Denny PA, Xie Y et al. Glycoprofiling of the human salivary proteome. Clin. Proteomics 5(1), 52-68 (2009).
25. Messana I, Inzitari R, Fanali C et al. Facts and artifacts in proteomics of body fluids. What proteomics of saliva is telling us? J. Sep. Sci. 31(11), 1948-1963 (2008). (Pubitemid 352003180)
26. Castagnola M, Inzitari R, Fanali C et al. The surprising composition of the salivary proteome of preterm human newborn. Mol. Cell. Proteomics 10(1), M110.003467 (2011). • ?Top-down proteomics gave relevant qualitative and quantitative information on the salivary proteome of human preterm newborns, suggesting coordinate and hierarchical functions of these proteins during development.
27. Iontcheva I, Oppenheim FG, Troxler RF. Human salivary mucin MG1 selectively forms heterotypic complexes with amylase, proline-rich proteins, statherin, and histatins. Dent. Res. 76(3), 734-743 (1997). (Pubitemid 127732662)
28. Vitorino R, Guedes S, Manadas B et al. Toward a standardized saliva proteome analysis methodology. J. Proteomics 75(17), 5140-5165 (2012).
29. Vitorino R, Barros A, Caseiro A et al. Towards defining the whole salivary peptidome. Proteomics Clin. Appl. 3(5), 528-540 (2009).
30. Thomadaki K, Helmerhorst EJ, Tian N et al. Whole-saliva proteolysis and its impact on salivary diagnostics. J. Dent. Res. 90(11), 1325-1330 (2011).
31. Amado FM, Lobo MJ, Domingues P et al. Salivary peptidomics. Expert Rev. Proteomics 7(5), 709-721 (2010).
32. Amado FM, Ferreira RP, Vitorino R. One decade of salivary proteomics: current approaches and outstanding challenges. Clin. Biochem. 46(6), 506-517 (2013). • Emphasizes methodological concerns related to saliva collection, treatment and analysis, and the main advantages and pitfalls underlying salivary proteomic strategies.
33. Takehara S, Yanagishita M, Podyma-Inoue KA, Kawaguchi Y. Degradation of MUC7 and MUC5B in human saliva. PLoS ONE 8(7), e69059 (2013).
34. Helmerhorst EJ, Traboulsi G, Salih E, Oppenheim FG. Mass spectrometric identification of key proteolytic cleavage sites in statherin affecting mineral homeostasis and bacterial binding domains. J. Proteome Res. 9(10), 5413-5421 (2010).
35. Morzel M, Jeannin A, Lucchi G et al. Human infant saliva peptidome is modified with age and diet transition. J. Proteomics 75(12), 3665-3673 (2012).
36. Hardt M, Witkowska HE, Webb S et al. Assessing the effects of diurnal variation on the composition of human parotid saliva: quantitative analysis of native peptides using iTRAQ reagents. Anal. Chem. 77(15), 4947-4954 (2005). (Pubitemid 41076686)
37. Thomadaki K, Bosch JA, Oppenheim FG, Helmerhorst EJ. The diagnostic potential of salivary protease activities in periodontal health and disease. Oral Dis. 19(8), 781-788 (2013).
38. Cabras T, Pisano E, Mastinu A et al. Alterations of the salivary secretory peptidome profile in children affected by type 1 diabetes. Mol. Cell. Proteomics 9(10), 2099-2108 (2010).
39. Huq NL, Cross KJ, Ung M et al. A review of the salivary proteome and peptidome and saliva-derived peptide therapeutics. Int. J. Pept. Res. Ther. 13(4), 547-564 (2007). (Pubitemid 350060783)
40. Hardt M, Thomas LR, Dixon SE et al. Toward defining the human parotid gland salivary proteome and peptidome: identification and characterization using 2D SDS-PAGE, ultrafiltration, HPLC, and mass spectrometry. Biochemistry 44(8), 2885-2899 (2005). (Pubitemid 40293663)
41. Inzitari R, Cabras T, Onnis G et al. Different isoforms and post-translational modifications of human salivary acidic proline-rich proteins. Proteomics 5(3), 805-815 (2005). (Pubitemid 40316065)
42. Inzitari R, Cabras T, Rossetti DV et al. Detection in human saliva of different statherin and P-B fragments and derivatives. Proteomics 6(23), 6370-6379 (2006). (Pubitemid 44935520)
43. Inzitari R, Vento G, Capoluongo E et al. Proteomic analysis of salivary acidic proline-rich proteins in human preterm and at-term newborns. J. Proteome Res. 6(4), 1371-1377 (2007). (Pubitemid 46724034)
44. Robinson S, Niles RK, Witkowska HE et al. A mass spectrometry-based strategy for detecting and characterizing endogenous proteinase activities in complex biological samples. Proteomics 8(3), 435-445 (2008). (Pubitemid 351252003)
45. Campese M, Sun X, Bosch JA et al. Concentration and fate of histatins and acidic proline-rich proteins in the oral environment. Arch. Oral Biol. 54(4), 345-353 (2009).
46. Iavarone F, Cabras T, Pisano E et al. Top-down HPLC-ESI-MS detection of S-glutathionylated and S-cysteinylated derivatives of cystatin B and its 1-53 and 54-98 fragments in whole saliva of human preterm newborns. J. Proteome Res. 12(2), 917-926 (2013).
47. Cabras T, Pisano E, Montaldo C et al. Significant modifications of the salivary proteome potentially associated with complications of Down syndrome revealed by top-down proteomics. Mol. Cell. Proteomics 12(7), 1844-1852 (2013).
48. Cabras T, Pisano E, Boi R et al. Age-dependent modifications of the human salivary secretory protein complex. J. Proteome Res. 8(8), 4126-4134 (2009).
49. Helmerhorst EJ, Zamakhchari M, Schuppan D, Oppenheim FG. Discovery of a novel and rich source of gluten-degrading microbial enzymes in the oral cavity. PLoS ONE 5(10), e13264 (2010).
50. Fernandez-Feo M, Wei G, Blumenkranz G et al. The cultivable human oral gluten-degrading microbiome and its potential implications in coeliac disease and gluten sensitivity. Clin. Microbiol. Infect. 19(9), E386-E394 (2013).
51. Vitorino R, Calheiros-Lobo MJ, Williams J et al. Peptidomic analysis of human acquired enamel pellicle. Biomed. Chromatogr. 21(11), 1107-1117 (2007). (Pubitemid 350200889)
52. Starheim KK, Gevaert K, Arnesen T et al. Protein N-terminal acetyltransferases: when the start matters. Trends Biochem. Sci. 37(4), 152-161 (2012).
53. Van Damme P, Hole K, Pimenta-Marques A et al. NatF contributes to an evolutionary shift in protein N-terminal acetylation and is important for normal chromosome segregation. PLoS Genet. 7(7), e1002169 (2011).
54. Dormeyr W, Mohammed S, Breukelen BV et al. Targeted analysis of protein termini. J. Proteome Res. 6(12), 4634-4645 (2007).
55. Foyn H, Van Damme P, Støve SI et al. Protein N-terminal acetyltransferases act as N-terminal propionyltransferases in vitro and in vivo. Mol. Cell. Proteomics 12(1), 42-54 (2013).
56. Weinert BT, Schölz C, Wagner SA et al. Lysine succinylation is a frequently occurring modification in prokaryotes and eukaryotes and extensively overlaps with acetylation. Cell. Rep. 4(4), 842-851 (2013).
57. Schilling S, Wasternack C, Demuth HU. Glutaminyl cyclases from animals and plants: a case of functionally convergent protein evolution. Biol. Chem. 389(8), 983-991 (2008).
58. Steiner DF. The proprotein convertases. Curr. Opin. Chem. Biol. 2(1), 31-39 (1998). (Pubitemid 128419196)
59. Song L, Fricker LD. Cloning and expression of human carboxypeptidase Z, a novel metallocarboxypeptidase. J. Biol. Chem. 272(16), 10543-10550 (1997). (Pubitemid 27181060)
60. Tagliabracci VS, Engel JL, Wen J et al. Secreted kinase phosphorylates extracellular proteins that regulate biomineralization. Science 336 (6085), 1150-1153 (2012). • The identity of the elusive Golgi casein kinase has been revealed with the discovery of Fam20C, a family of atipical secreted protein kinases that appear to phosphorylate numerous extracellular proteins.
61. Monigatti F, Hekking,B, Steen H. Protein sulfation analysis-A primer. Biochim. Biophys. Acta 1764(12), 1904-1913 (2006). (Pubitemid 44895021)
62. Onnerfjord P, Heathfield TF, Heinegård D. Identification of tyrosine sulfation in extracellular leucine-rich repeat proteins using mass spectrometry. J. Biol. Chem. 279(1), 26-33 (2004). (Pubitemid 38044795)
63. Kasinathan C, Gandhi N, Ramaprasad P et al. Tyrosine sulfation of statherin. Int. J. Biol. Sci. 3(4), 237-241 (2007). (Pubitemid 46425507)
64. Ryan CM, Souda P, Halgand F et al. Confident assignment of intact mass tags to human salivary cystatins using top-down Fourier-transform ion cyclotron resonance mass spectrometry. J. Am. Soc. Mass Spectrom. 21(6), 908-917 (2010).
65. Carpenter GH, Proctor GB. O-linked glycosylation occurs on basic parotid salivary proline-rich proteins. Oral Microbiol. Immunol. 14(5), 309-315 (1999). (Pubitemid 29447093)
66. Vitorino R, Alves R, Barros A et al. Finding new posttranslational modifications in salivary proline-rich proteins. Proteomics 10(20), 3732-3742 (2010).
67. Cabras T, Boi R, Pisano E et al. HPLC-ESI-MS and MS/MS structural characterization of multifucosylated N-glycoforms of the basic proline-rich protein IB-8a CON1+ in human saliva. J. Sep. Sci. 35(9), 1079-1086 (2012).
68. Everest-Dass AV, Abrahams JL, Kolarich D et al. Structural feature ions for distinguishing N- and O-linked glycan isomers by LC-ESI-IT MS/MS. J. Am. Soc. Mass Spectrom. 24(6), 895-906 (2013).
69. Oppenheim FG, Salih E, Siqueira WL et al. Salivary proteome and its genetic polymorphisms. Ann. NY Acad. Sci. 1098, 22-50 (2007). (Pubitemid 47092551)
70. Karlsson NG, Thomsson KA. Salivary MUC7 is a major carrier of blood group I type O-linked oligosaccharides serving as the scaffold for sialyl Lewis x. Glycobiology 19(3), 288-300 (2009).
71. Thomsson KA, Prakobphol A, Leffler H et al. The salivary mucin MG1 (MUC5B) carries a repertoire of unique oligosaccharides that is large and diverse. Glycobiology 12(1), 1-14 (2002). (Pubitemid 34223395)
72. Prakobphol A, Boren T, Ma W, Zhixiang P et al. Highly glycosylated human salivary molecules present oligosaccharides that mediate adhesion of leukocytes and Helicobacter pylori. Biochemistry 44(6), 2216-2224 (2005). (Pubitemid 40223649)
73. Issa S, Moran AP, Ustinov SN et al. O-linked oligosaccharides from salivary agglutinin: Helicobacter pylori binding sialyl-Lewis x and Lewis b are terminating moieties on hyperfucosylated oligo-N-acetyllactosamine. Glycobiology 20(8), 1046-1057 (2010).
74. Grek CL, Zhang J, Manevich Y et al. Causes and consequences of cysteine S-glutathionylation. J. Biol. Chem. 288(37), 26497-26504 (2013). • ?Discusses the critical role of reversible protein S-glutathionylation, its involvement in the regulation of certain protein functional clusters, and the possible use of S-glutathionylation as a biomarker.
75. Levine RL, Berlett BS, Moskovitz J et al. Methionine residues may protect proteins from critical oxidative damage. Mech. Ageing Dev. 107(3), 323-332 (1999). (Pubitemid 29210232)
76. Cremers CM, Jakob U. Oxidant sensing by reversible disulfide bond formation. J. Biol. Chem. 288(37), 26489-26496 (2013).
77. Wang Y, Liu T, Wu C, Li H. A strategy for direct identification of protein S-nitrosylation sites by quadrupole time-of-flight mass spectrometry. J. Am. Soc. Mass Spectrom. 19(9), 1353-1360 (2008).
78. Cabras T, Manconi B, Iavarone F et al. RP-HPLC-ESI-MS evidenced that salivary cystatin B is detectable in adult human whole saliva mostly as S-modified derivatives: S-glutathionyl, S-cysteinyl and S-S 2-mer. J. Proteomics 75(3), 908-913 (2012).
79. Manconi B, Cabras T, Pisano E et al. Characterization of two isoforms of human SPRR3 from saliva of preterm human newborn and autoptic fetal oral mucosa, parotid and submandibular gland samples. Biochem. Biophys. Res. Commun. 398(3), 477-481 (2010).
80. Lupi A, Messana I, Denotti G et al. Identification of the human salivary cystatin complex by the coupling of high-performance liquid chromatography and ion-trap mass spectrometry. Proteomics 3(4), 461-467 (2003). (Pubitemid 36428298)
81. Fanali C, Inzitari R, Cabras T et al. Alpha-defensin levels in whole saliva of totally edentulous subjects. Int. J. Immunopathol. Pharmacol. 21(4), 845-849 (2008).
82. Gomes LH, Raftery MJ, Yan WX et al. S100A8 and S100A9-oxidant scavengers in inflammation. Free Radic. Biol. Med. 58, 170-186 (2013).
83. Nemolato S, Messana I, Cabras T et al. Thymosin beta(4) and beta(10) levels in preterm newborn oral cavity and foetal salivary glands evidence a switch of secretion during foetal development. PLoS ONE 4(4), e5109 (2009).
84. Inzitari R, Cabras T, Pisano E et al. HPLC-ESI-MS analysis of oral human fluids reveals that gingival crevicular fluid is the main source of oral thymosins beta(4) and beta(10). J. Sep. Sci. 32(1), 57-63 (2009).
85. Manconi B, Cabras T, Pisano E et al. Modifications of the acidic soluble salivary proteome in human children from birth to the age of months investigated by a top-down HPLC-ESI-MS platform. J. Proteomics 91, 536-543 (2013).
86. Morzel M, Palicki O, Chabanet C et al. Saliva electrophoretic protein profiles in infants: changes with age and impact of teeth eruption and diet transition. Arch. Oral Biol. 56(7), 634-642 (2011).
87. Castagnola M, Cabras T, Vitali A et al. Biotechnological implications of the salivary proteome. Trends Biotechnol. 29(8), 409-418 (2011).
88. Al-Tarawneh SK, Border MB, Dibble CF, Bencharit S. Defining salivary biomarkers using mass spectrometry-based proteomics: a systematic review. OMICS 15(6), 353-361 (2011).
89. Ohshiro K, Rosenthal DI, Koomen JM et al. Pre-analytic saliva processing affect proteomic results and biomarker screening of head and neck squamous carcinoma. Int. J. Oncol. 30(3), 743-749 (2007).
90. Hu S, Yu T, Xie Y et al. Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry. Cancer Genomics Proteomics 4(2), 55-64 (2007). (Pubitemid 46632026)
91. Jou YJ, Lin CD, Lai CH et al. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer. Anal. Chim. Acta 681(1-2), 41-48 (2010).
92. Shintani S, Hamakawa H, Ueyama Y et al. Identification of a truncated cystatin SA-I as a saliva biomarker for oral squamous cell carcinoma using the SELDI ProteinChip platform. Int. J. Oral Maxillofac. Surg. 39(1), 68-74 (2010).
93. Jou YJ, Lin CD, Lai CH et al. Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages. Clin. Chim. Acta 412(15-16), 1357-1365 (2011).
94. Xiao H, Zhang L, Zhou H et al. Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry. Mol. Cell. Proteomics 11(2), M111.012112 (2012).
95. Terracciano R, Preianò M, Palladino GP et al. Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases. Proteomics 11(6), 3402-3414 (2011).
96. Jarai T, Maasz G, Burian A et al. Mass spectrometry-based salivary proteomics for the discovery of head and neck squamous cell carcinoma. Pathol. Oncol. Res. 18(3), 623-628 (2012).
97. Dowling P, Wormald R, Meleady P et al. Analysis of the saliva proteome from patients with head and neck squamous cell carcinoma reveals differences in abundance levels of proteins associated with tumour progression and metastasis. J. Proteomics 71(2), 168-175 (2008). (Pubitemid 351915861)
98. Streckfus CF, Bigler LR, Zwick M. The use of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to detect putative breast cancer markers in saliva: a feasibility study. J. Oral Pathol. Med. 35(5), 292-300 (2006).
99. Wu ZZ, Wang JG, Zhang XL. Diagnostic model of saliva protein finger print analysis of patients with gastric cancer. World J. Gastroenterol. 15(7), 865-870 (2009).
100. Wu Y, Shu R, Luo LJ et al. Initial comparison of proteomic profiles of whole unstimulated saliva obtained from generalized aggressive periodontitis patients and healthy control subjects. J. Periodontal Res. 44(5), 636-644 (2009).
101. Gonçalves L da R, Soares MR, Nogueira FC et al. Comparative proteomic analysis of whole saliva from chronic periodontitis patients. J. Proteomics 73(7), 1334-1341 (2010).
102. Haigh BJ, Stewart KW, Whelan JR et al. Alterations in the salivary proteome associated with periodontitis. J. Clin. Periodontol. 37(3), 241-247 (2010).
103. Rangé H, Léger T, Huchon C et al. Salivary proteome modifications associated with periodontitis in obese patients. J. Clin. Periodontol. 39(9), 799-806 (2012).
104. Ellias MF, Zainal Ariffin SH, Karsani SA et al. Proteomic analysis of saliva identifies potential biomarkers for orthodontic tooth movement. ScientificWorldJournal 647240 (2012).
105. Preza D, Thiede B, Olsen I, Grinde B. The proteome of the human parotid gland secretion in elderly with and without root caries. Acta Odontol. Scand. 67(3), 161-169 (2009).
106. Vitorino R, de Morais Guedes S, Ferreira R et al. Two-dimensional electrophoresis study of in vitro pellicle formation and dental caries susceptibility. Eur. J. Oral Sci. 114(2), 147-153 (2006). (Pubitemid 43480637)
107. Bencharit S, Altarawneh SK, Baxter SS et al. Elucidating role of salivary proteins in denture stomatitis using a proteomic approach. Mol. Biosyst. 8(12), 3216-3223 (2012).
108. Ryu OH, Atkinson JC, Hoehn GT et al. Identification of parotid salivary biomarkers in Sjögren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology (Oxford) 45(9), 1077-1086 (2006). (Pubitemid 44542092)
109. Giusti L, Baldini C, Bazzichi L et al. Proteome analysis of whole saliva: a new tool for rheumatic diseases: the example of Sjögren's syndrome. Proteomics 7(10), 1634-1643 (2007). (Pubitemid 46844748)
110. Hu S, Wang J, Meijer J et al. Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. Arthritis Rheum. 56(11), 3588-3600 (2007). (Pubitemid 350100692)
111. Fleissig Y, Deutsch O, Reichenberg E et al. Different proteomic protein patterns in saliva of Sjogren's syndrome patients. Oral Dis. 15(1), 61-68 (2009).
112. Baldini C, Giusti L, Ciregia F et al. Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes. Arthritis Res. Ther. 13(6), R194 (2011).
113. Wei P, Kuo WP, Chen F, Hua H. Diagnostic model of saliva peptide finger print analysis of primary Sjögren's syndrome patients by using weak cation exchange magnetic beads. Biosci. Rep. 33(4), pii: e00051 (2013).
114. Peluso G, De Santis M, Inzitari R et al. Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment. Arthritis Rheum. 56(7), 2216-2222 (2007). (Pubitemid 47173569)
115. Giusti L, Bazzichi L, Baldini C et al. Specific proteins identified in whole saliva from patients with diffuse systemic sclerosis. J. Rheumatol. 34(10), 2063-2069 (2007). (Pubitemid 47548211)
116. Giusti L, Baldini C, Ciregia F et al. Is GRP78/BiP a potential salivary biomarker in patients with rheumatoid arthritis? Proteomics Clin. Appl. 4(3), 315-324 (2010).
117. Hirtz C, Chevalier F, Sommerer N et al. Salivary protein profiling in type 1 diabetes using two-dimensional electrophoresis and mass spectrometry. Clin. Proteomics 2(1-2), 117-128 (2006).
118. Caseiro A, Vitorino R, Barros AS et al. Salivary peptidome in Type 1 diabetes mellitus. Biomed. Chromatogr. 26(5), 571-582 (2012).
119. Bazzichi L, Ciregia F, Giusti L et al. Detection of potential markers of primary fibromyalgia syndrome in human saliva. Proteomics Clin. Appl. 3(11), 1296-1304 (2009).
120. Chiusolo P, Giammarco S, Fanali C et al. Salivary proteomic analysis and acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant 19(6), 888-892 (2013).
121. Imanguli MM, Atkinson JC, Harvey KE et al. Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation. Exp. Hematol. 35(2), 184-192 (2007). (Pubitemid 46135822)
122. Castagnola M, Messana I, Inzitari R et al. Hypo-phosphorylation of salivary peptidome as a clue to the molecular pathogenesis of autism spectrum disorders. J. Proteome Res. 7, 5327-5332 (2008).
123. Dodds MW, Johnson DA, Yeh CK. Health benefits of saliva: a review. J. Dent. 33(3), 223-233 (2005). (Pubitemid 40276809)
124. Van Nieuw Amerongen A, Bolscher JG, Veerman EC. Salivary proteins: protective and diagnostic value in cariology? Caries Res. 38(3), 247-253 (2004). (Pubitemid 38716217)
125. Amerongen AV, Veerman EC. Saliva-the defender of the oral cavity. Oral Dis. 8(1), 12-22 (2002).
126. Lee YH, Zimmerman JN, Custodio W et al. Proteomic evaluation of acquired enamel pellicle during in vivo formation. PLoS ONE 8(7), e67919 (2013).
127. Siqueira WL, Custodio W, McDonald EE. New insights into the composition and functions of the acquired enamel pellicle. J. Dent. Res. 91(12), 1110-1118 (2012).
128. Rudney JD. Saliva and dental plaque. Adv. Dent. Res. 14, 29-39 (2000).
129. Oudhoff MJ, Bolscher JG, Nazmi K et al. Histatins are the major wound-closure stimulating factors in human saliva as identified in a cell culture assay. FASEB J. 22(11), 3805-3812 (2008). • Demonstrates the relevant function of histatins in oral wound healing.
130. Bennick A. Extraoral functions of salivary proteins. J. Oral Biosci. 49(1), 24-26 (2007).
131. Soares S, Vitorino R, Osório H et al. Reactivity of human salivary proteins families toward food polyphenols. J. Agric. Food Chem. 59(10), 5535-5547 (2011).
132. Ya Y, Lamkin MS, Oppenheim FG. Pellicle precursor protein crosslinking characterization of an adduct between acidic proline-rich protein (PRP-1) and statherin generated by transglutaminase. J. Dent. Res. 79(4), 930-938 (2000). (Pubitemid 32501304)
133. Melis M, Aragoni MC, Arca M et al. Marked increase in PROP taste responsiveness following oral supplementation with selected salivary proteins or their related free amino acids. PLoS ONE 8(3), e59810 (2013).
134. Cabras T, Melis M, Castagnola M et al. Responsiveness to 6-n-propylthiouracil (PROP) is associated with salivary levels of two specific basic proline-rich proteins in humans. PLoS ONE 7(2), e30962 (2012).